XH-S003 Capsule

DRUG3 trials

Sponsors

S-INFINITY Pharmaceuticals Co., Ltd

Conditions

IgA NephropathyPNH - Paroxysmal Nocturnal HemoglobinuriaParoxysmal Nocturnal Hemoglobinuria

Phase 2

A Phase II Study Evaluating the Efficacy and Safety of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)

RecruitingNCT06978699

S-INFINITY Pharmaceuticals Co., LtdPNH - Paroxysmal Nocturnal Hemoglobinuria

Start: 2025-04-30End: 2026-10-30Target: 24Updated: 2025-05-18

A Phase IIa Study in Primary IgA Nephropathy Patients

CompletedNCT07634744

S-INFINITY Pharmaceuticals Co., LtdIgA Nephropathy

Start: 2024-12-31End: 2026-04-23Updated: 2026-06-09

Unknown Phase

A Multicenter, Open-label Study Evaluating the Long-term Safety and Efficacy of XH-S003 Capsules in Patients With Paroxysmal Nocturnal Hemoglobinuria

Enrolling by invitationNCT07657052

S-INFINITY Pharmaceuticals Co., LtdParoxysmal Nocturnal Hemoglobinuria

Start: 2025-08-15End: 2029-09-30Target: 26Updated: 2026-06-18